Health Care · Services-Health Services

PNTG Pennant Group, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 176640091 filings
Russell 2000

PNTG at a glance

Pennant Group, Inc. (PNTG, SEC CIK 1766400) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as November 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Pennant Group, Inc. (PNTG) reported revenue of $947.7 million (up 36.3% from FY2024) and net income of $29.6 million. Diluted EPS was $0.84.
  • As of September 30, 2026, 28 institutional investment managers tracked by SignalX reported holding Pennant Group, Inc. (PNTG) shares worth $429.8 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Steik Jason Paul on November 17, 2026 of 218 shares at $37.15 per share.
  • In the last 90 days, PNTG insiders reported 0 open-market purchases ($0) and 1 open-market sale ($8K) on Form 4, a net sale of $8K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$947.7M
+36.3% vs prior year
Insiders · 90 days
0 buys · 1 sell
Net −$8K
13F holders
28 funds
$429.8M · −2 vs prior quarter
Latest 8-K
Nov 4, 2026
Item 7.01 · Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Management of senior living communities primarily through leasing arrangements and healthcare service provision
  • Strategic emphasis on managing increased liability and insurance cost risks due to new state legislation affecting insurance premiums in Nevada, California, and Iowa
  • Workforce unionization risk heightened reflecting broader healthcare industry trends, posing potential operational disruptions and increased costs
  • As of Dec 31, 2025, majority of senior living communities leased under triple-net leases exposing firm to lease default and cross-default risks
  • Inflationary pressures impacting wages, supplies, energy costs alongside uncertain reimbursement adjustments from Medicare and Medicaid programs

Risk Factors

  • Regulatory risk from Medicare payment methodology under PDGM, affecting revenue per 60-day episode averaging $3,755 in 2025
  • Geopolitical/macro threat from inflation impacting senior living revenue growth despite occupancy increase to 79.7% in 2025
  • Operational risk due to integration challenges and cost fluctuations from large 2025 acquisition of 30 home health and hospice agencies in southeastern U.S.
  • Competitive risk from highly competitive senior living market affecting resident occupancy and pricing power
  • Financial risk from reliance on lease agreements for real estate, with rent costs at 5.1% of revenue in 2025 impacting margins

Management Discussion & Analysis

  • Net cash from operations $48.3M, up $9.0M YoY driven by $9.4M net income increase and $2.5M change in working capital
  • Investing cash outflow $228.0M, up $157.3M YoY mainly due to $154.7M increase in acquisitions and $3.0M capex increase
  • Financing cash inflow $172.5M, up $122.9M YoY mainly from $140.0M more from revolving credit and $100.0M incremental term loans
  • $17.0M cash balance, $171.6M available borrowing capacity on revolving credit as of Dec 31, 2025
  • Management sees sufficient liquidity for next 12 months from cash, operations, and credit facility access

AI summary of the PNTG 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • New Connecticut joint operating arrangement, $28,428 investment creating equity-method exposure and operational integration risk
  • Debt increased to $199,250, including $103,000 revolver and $96,250 term loans, with 6.08% weighted-average interest
  • Medicare and Medicaid receivables 70.7% of total, exposing liquidity to governmental payment delays and recoupments
  • Medicare Reviews remain active across subsidiaries, with potential sanctions, extrapolated recoupments, fines, or program termination
  • Master lease defaults could cross-trigger obligations across 15 senior living communities under three arrangements

Management Discussion & Analysis

  • Revenue $302.3M, up 32.0% YoY from $229.0M, driven by acquired agencies and communities
  • Operating margin 5.5% vs 4.4% YoY; net margin 3.7% vs 3.0%
  • Best segment: Home Health and Hospice revenue $239.8M, up 38.2%; adjusted EBITDAR $41.4M vs $29.1M
  • Worst segment: Senior Living occupancy 78.4% vs 80.9%; cost margin 75.0% vs 73.0%
  • Cash $18.4M; operating cash flow $43.5M, investing outflow $68.5M, acquisitions and enrollment moratorium headwinds

AI summary of the PNTG 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 4, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Updated investor presentation signals new or refreshed messaging for upcoming investor meetings
  • Materials available at investor.pennantgroup.com for investor review

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 financial results for quarter ended September 30, 2026
  • Press release provides Pennant Group’s detailed operating and financial results

Item EX-99.1: Item EX-99.1

  • Q3 revenue $302.3M, up 32.0%, with net income $9.6M up 58.5% and diluted EPS $0.26
  • Adjusted diluted EPS $0.35 versus $0.30, while adjusted EBITDA rose 42.4% to $24.7M
Filed Aug 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results for quarter ended June 30, 2026
  • Press release issued August 5, 2026

Item 7.01: Regulation FD Disclosure

  • Updated investor presentation intended for upcoming investor meetings
  • Materials available at investor.pennantgroup.com

Item EX-99.1: Item EX-99.1

  • Q2 revenue $298.0M, up 35.8%, with GAAP diluted EPS $0.25 and adjusted EPS $0.36
  • Adjusted EBITDA $24.3M, up 48.2%, outpacing revenue growth and signaling operating leverage
Filed May 20, 2026Full analysis →

Item 5.07: Submission of Matters to a Vote of Security Holders

  • 30.49M shares voted at the May 14, 2026 annual meeting, representing broad shareholder participation
  • Christensen, Guerisoli, and Nackel elected as Class I directors through the 2029 annual meeting

AI summaries of PNTG 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for PNTG

Don't miss the next PNTG filing

  • Alerts as it files. A push when PNTG files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut PNTG, by share count.
  • Ask anything. An AI agent that reads every PNTG filing and answers with sources.

PNTG alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Steik Jason PaulSellNov 17, 2026$37.15
SMITH BARRY MGNov 10, 2026$36.74
Gochnour John JMOct 23, 2026$6.10
Gochnour John JMOct 23, 2026$6.10
Gochnour John JFOct 23, 2026$42.05
Snapper Suzanne D.AOct 15, 2026-
SMITH BARRY MAOct 15, 2026-
Lamb Scott EAOct 15, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$695.2M$947.7M
Operating Income$25.2M$38.1M$51.9M
Net Income$13.4M$22.6M$29.6M
Op. Margin-5.5%5.5%
Net Margin-3.2%3.1%
Balance Sheet
Total Assets-$679.5M$968.2M
Equity-$312.0M$374.3M
ROE-7.2%7.9%
Per Share
EPS$0.44$0.70$0.84
Cash Flow
Operating CF-$39.3M$48.3M
CapEx$8.1M$9.0M$12.0M

Source: XBRL data in Pennant Group, Inc. (PNTG)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate PNTG share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
PNTG shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202628$429.8M
Q2 202630$433.6M
Q1 202629$334.3M
Q4 202527$316.9M
Q3 202529$274.3M
Q2 202528$385.9M
Q1 202525$246.4M
Q4 202421$245.3M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
None this quarter.
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 217 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

PNTG filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 19, 2026--
4Nov 13, 2026--
10-QNov 4, 2026Analysis
8-KNov 4, 2026Analysis-
4Oct 27, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Aug 10, 2026--
4Aug 10, 2026--
4Aug 10, 2026--
10-QAug 5, 2026Analysis
8-KAug 5, 2026Analysis-
SC 13GJul 31, 2026-
4Jul 17, 2026--
SC 13GJul 17, 2026-
4Jul 17, 2026--
4Jul 17, 2026--
4Jul 17, 2026--
4Jul 17, 2026--
4Jul 17, 2026--

Related Health Care companies

All Health Care →

PNTG SEC filings: frequently asked questions

Are PNTG insiders buying or selling?

In the last 90 days, Pennant Group, Inc. (PNTG) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $8,098 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold PNTG stock?

As of September 30, 2026, the largest Pennant Group, Inc. (PNTG) holders among the 13F filers tracked by SignalX were BlackRock ($115.3 million), Vanguard Capital Management LLC ($57.6 million), State Street Corp ($35.3 million), Dimensional Fund Advisors ($33.9 million), Goldman Sachs Group ($32.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was PNTG's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Pennant Group, Inc. (PNTG) reported revenue of $947.7 million (up 36.3% from FY2024) and net income of $29.6 million. Diluted EPS was $0.84. The figures come from the XBRL data in the 10-K.

What are the main risks in PNTG's latest 10-K?

In the 10-K filed February 26, 2026, Pennant Group, Inc. (PNTG) flagged: Regulatory risk from Medicare payment methodology under PDGM, affecting revenue per 60-day episode averaging $3,755 in 2025. Geopolitical/macro threat from inflation impacting senior living revenue growth despite occupancy increase to 79.7% in 2025. (AI summary of the Risk Factors section.)

What did PNTG report in its latest 8-K?

Pennant Group, Inc. (PNTG) filed an 8-K on November 4, 2026 reporting Item 7.01 (Regulation FD Disclosure) and Item 2.02 (Results of Operations and Financial Condition). Updated investor presentation signals new or refreshed messaging for upcoming investor meetings.

What are the latest PNTG SEC filings?

Pennant Group, Inc. (PNTG) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on November 19, 2026.

What is PNTG's SEC CIK number?

Pennant Group, Inc. (PNTG)'s SEC Central Index Key (CIK) is 1766400. EDGAR lists every PNTG filing under that number.

Ask anything about PNTG

The research agent reads PNTG's filings, financials, insider trades and 13F holders, then answers with sources.